DexCom, Inc. (DXCM) vs Medline Inc. (MDLN)
MDLN leads on 6 of 11 compared metrics.
A side-by-side comparison of DexCom, Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — DXCM vs MDLN
growth of $100 · last 1yDXCM +14.4%MDLN -7.3%DXCM compounded faster
DXCM MDLN
DXCM vs MDLN: by the numbers
- •MDLN is the larger company ($30.96B vs $29.08B market cap).
- •MDLN trades at the lower earnings multiple (30.26 vs 32.21 P/E).
- •DXCM converts more revenue to profit (19.31% vs 3.31% net margin).
Which is better, DXCM or MDLN?
Metric tally: DXCM 5 · MDLN 6It depends on what you're optimizing for:
ValueMDLN(lower P/E)
QualityDXCM(higher ROIC)
Valuation
| Metric | DXCM | MDLN |
|---|---|---|
| P/E ratio | 32.21 | 30.26● |
| Forward P/E | 24.42 | 22.08● |
| P/S ratio | 6.16 | 1.04● |
| P/B ratio | 10.03 | 2.68● |
| PEG ratio | 0.66 | — |
| EV / EBITDA | 20.28 | 14.84● |
| FCF yield | 4.82% | 5.05%● |
Profitability
| Metric | DXCM | MDLN |
|---|---|---|
| Gross margin | 61.84%● | 24.04% |
| Operating margin | 21.45%● | 7.04% |
| Net margin | 19.31%● | 3.31% |
| ROE | 31.47%● | 8.55% |
| ROIC | 16.61%● | 5.69% |
Growth (annualized)
| Metric | DXCM | MDLN |
|---|---|---|
| Revenue CAGR (5Y) | 18.91% | — |
| EPS CAGR (5Y) | 10.31% | — |
| FCF CAGR (5Y) | 43.37% | — |
| Total return CAGR (5Y) | -5.51% | — |
Frequently asked
- Which is better, DXCM or MDLN?
- It depends on your goal. value: MDLN (lower P/E); quality: DXCM (higher ROIC). Across all compared metrics, MDLN leads 6 to 5.
- Is DXCM or MDLN cheaper?
- On trailing earnings, MDLN is cheaper: DXCM trades at a 32.21 P/E and MDLN at 30.26.
- Is DXCM or MDLN more profitable?
- DXCM runs the higher net margin — DXCM at 19.31% versus MDLN at 3.31%.
Go deeper
Dig into the metrics
DexCom P/E ratioMedline P/E ratioDexCom dividend yieldMedline dividend yieldDexCom ROEMedline ROEDexCom operating marginMedline operating marginDexCom revenue growthMedline revenue growthDexCom free cash flowMedline free cash flow
DexCom & Medline appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.